Biora Therapeutics, Inc. (BIOR)
NASDAQ: BIOR · IEX Real-Time Price · USD
0.730
-0.008 (-1.03%)
At close: May 17, 2024, 4:00 PM
0.749
+0.019 (2.63%)
After-hours: May 17, 2024, 7:53 PM EDT
Biora Therapeutics Market Cap
Biora Therapeutics has a market cap or net worth of $26.44 million as of May 17, 2024. Its market cap has decreased by -32.02% in one year.
Market Cap
26.44M
Enterprise Value
60.88M
1-Year Change
-32.02%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since June 19, 2020, Biora Therapeutics's market cap has decreased from $592.50M to $26.44M, a decrease of -95.54%. That is a compound annual growth rate of -54.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 17, 2024 | 26.20M | -0.76% |
May 16, 2024 | 26.40M | 2.72% |
May 15, 2024 | 25.70M | 14.73% |
May 14, 2024 | 22.40M | - |
May 13, 2024 | 22.40M | 0.90% |
May 10, 2024 | 22.20M | -2.20% |
May 9, 2024 | 22.70M | 4.61% |
May 8, 2024 | 21.70M | -3.13% |
May 7, 2024 | 22.40M | -1.75% |
May 6, 2024 | 22.80M | 2.70% |
May 3, 2024 | 22.20M | 2.78% |
May 2, 2024 | 21.60M | 10.77% |
May 1, 2024 | 19.50M | -2.01% |
Apr 30, 2024 | 19.90M | 5.29% |
Apr 29, 2024 | 18.90M | -0.53% |
Apr 26, 2024 | 19.00M | 3.26% |
Apr 25, 2024 | 18.40M | -2.13% |
Apr 24, 2024 | 18.80M | -3.09% |
Apr 23, 2024 | 19.40M | 5.43% |
Apr 22, 2024 | 18.40M | -1.08% |
Apr 19, 2024 | 18.60M | 2.20% |
Apr 18, 2024 | 18.20M | -6.67% |
Apr 17, 2024 | 19.50M | 3.72% |
Apr 16, 2024 | 18.80M | - |
Apr 15, 2024 | 18.80M | -7.39% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Singular Genomics Systems | 28.89M |
DURECT | 28.86M |
Aprea Therapeutics | 28.62M |
Femasys | 28.44M |
Oncternal Therapeutics | 26.48M |
Qilian International Holding Group | 26.26M |
Enlivex Therapeutics | 26.22M |
bioAffinity Technologies | 26.14M |